Clinical and preclinical data have indicated a mitogenic role for small regulatory peptides such as endothelin-1 (ET-1), bradykinin, bombesin-like peptides and neurotensin in various stages of prostate cancer (Bologna et al, 1989; Papandreou et al, 1998). Here, EDN1 is linked to prostate cancer.